GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Exosens SA (XPAR:EXENS) » Definitions » EBIT

Exosens (XPAR:EXENS) EBIT : €32.4 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Exosens EBIT?

Exosens's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was €0.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was €32.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Exosens's annualized ROC % for the quarter that ended in Dec. 2024 was 0.00%. Exosens's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Exosens's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 1.89%.


Exosens EBIT Historical Data

The historical data trend for Exosens's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exosens EBIT Chart

Exosens Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
28.64 -112.67 32.26 52.80 77.00

Exosens Quarterly Data
Dec20 Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only 16.42 - 13.20 19.16 -

Competitive Comparison of Exosens's EBIT

For the Electrical Equipment & Parts subindustry, Exosens's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exosens's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Exosens's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Exosens's EV-to-EBIT falls into.



Exosens EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €32.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Exosens  (XPAR:EXENS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Exosens's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=0 * ( 1 - 0% )/( (608.752 + 640.8)/ 2 )
=0/624.776
=0.00 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=784.323 - 52.312 - ( 123.259 - max(0, 111.743 - 315.857+123.259))
=608.752

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Exosens's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0/( ( (89.341 + max(71.551, 0)) + (104.2 + max(59.7, 0)) )/ 2 )
=0/( ( 160.892 + 163.9 )/ 2 )
=0/162.396
=0.00 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(60.31 + 94.905 + 24.784) - (52.312 + 0 + 56.136)
=71.551

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(71 + 93 + 0) - (26 + 0 + 78.3)
=59.7

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Exosens's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=32.353/1714.540
=1.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Exosens EBIT Related Terms

Thank you for viewing the detailed overview of Exosens's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Exosens Business Description

Traded in Other Exchanges
Address
18 Avenue Pythagore, Domaine de Pelus - Axis Business Park - Bât 5 E, Merignac, FRA, 33700
Exosens SA is a high-tech company in innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. It offers its customers detection components and solutions such as travelling wave tubes, advanced cameras, neutron & gamma detectors, instrument detectors and light intensifier tubes. Its products include Night vision tubes, Ultra Violet cameras, Ion and electron detection, Gamma detectors, etc.

Exosens Headlines

No Headlines